Clinical Trial Update: Mepolizumab Pharmacokinetics Among Patients With Severe Asthma [NA]

View source ↗

Summary

A completed clinical trial update detailing the pharmacokinetics of mepolizumab in patients with severe asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Nucala (mepolizumab)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Asthma | NA | Status: COMPLETED